N-Nitroso Deucravacitinib
- CASnot assigned
- CatalogueRS-D081113
- FormulaC20H18D3N9O4
- MW454.47
On this page
Product identification
| Product name | N-Nitroso Deucravacitinib |
|---|---|
| Catalogue No. | RS-D081113 |
| CAS No. | not assigned |
| Molecular formula | C20H18D3N9O4 |
| Molecular weight | 454.47 |
| Exact mass | 454.1905 (monoisotopic) |
| InChIKey | OHXCAWRVRXPSPS-FIBGUPNXSA-N |
| Availability | Back order— restocking can be arranged, about 1–2 weeks |
| Standard type | Nitrosamine Standards |
| Drug substance | Deucravacitinib |
| Also known as | 6-(Cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)(nitroso)amino)-N-(methyl-d3)pyridazine-3-carboxamide |
| Storage | Refer to the certificate of analysis (COA) supplied with each lot |
| Intended use | For laboratory and research use only. Not for human or veterinary use. |
What is stated on the certificate
Content and purity are assigned per lot and stated on the certificate of analysis issued for the batch you receive — they are not a catalogue-level figure. The certificate records the tests performed, the specification applied and the result obtained for that lot.
| Field | Basis |
|---|---|
| Identity | Spectroscopic and chromatographic methods appropriate to the material |
| Purity | Chromatographic purity, area normalisation unless stated otherwise |
| Assay / content | Mass balance, corrected for the stated volatiles and residue |
| Catalogue and batch numbers | RS-D081113 / batch number on the certificate |
| Retest date | Printed on the certificate for the lot supplied |
Frequently asked
What documentation is supplied with this lot?
Is the assigned value given on an “as is” basis?
How should this material be stored?
Do you supply pack sizes other than those listed?
Finding this standard
Buyers reach this compound by CAS number, by catalogue number, through the drug substance it belongs to, or through the type of standard it is. Those routes all start here:
- Other impurities of Deucravacitinib
- Nitrosamine Standards of this kind
- Documents for this item (COA, SDS)
- Certificate of analysis for RS-D081113
- Request a quotation for RS-D081113
Searching another way? Send the structure, a SMILES string or the pharmacopoeial name — a CAS number is not required for a non-compendial impurity. Write to sales@rssechem.com.
Other standards of Deucravacitinib
All 49 further standards are on this page — 20 shown at first, then 20 more per click on Load more.
Deucravacitinib
IN STOCKRS-I0973801H-1,2,4-Triazole, 3-(5-chloro-2-methoxy-3-nitrophenyl)-1-methyl-
BACK ORDERRS-U0159132-(1-Methyl-1H-1,2,4-triazol-3-yl)-6-nitrophenol
CUSTOM SYNTHESISRS-I0154072-Methoxy-3-nitrobenzamide
IN STOCKRS-U0538672-Methoxy-3-nitrobenzonitrile
IN STOCKRS-U0533694,6-Dichloro-N-(methyl-d3)pyridazine-3-carboxamide
IN STOCKRS-D0810334,6-Dihydroxypyridazine-3-carboxylic acid
IN STOCKRS-I0101974-Bromo-2-methoxybenzonitrile
CUSTOM SYNTHESISRS-I012340BMS-986202
BACK ORDERRS-U091525Ethyl 4,6-dichloropyridazine-3-carboxylate
IN STOCKRS-U095312Ethyl 4-hydroxy-6-oxo-1,6-dihydropyridazine-3-carboxylate
IN STOCKRS-U095104Lithium 4,6-dichloropyridazine-3-carboxylate
IN STOCKRS-I017075Methyl 2-methoxy-3-nitrobenzimidothioate
IN STOCKRS-U082661Methyl 4,6-dichloropyridazine-3-carboxylate
IN STOCKRS-U082703Methyl 4-hydroxy-6-oxo-1,6-dihydropyridazine-3-carboxylate
IN STOCKRS-U082702Methyl 6-chloro-4-methylpyridazine-3-carboxylate
IN STOCKRS-U082063N-Methyl-N-formylhydrazine
IN STOCKRS-P025450Deucravacitinib N-Oxide Impurity 1
CUSTOM SYNTHESISRS-Z413DI9Deucravacitinib Impurity 4
IN STOCKRS-D081005Deucravacitinib Impurity 12
IN STOCKRS-D081008Deucravacitinib Impurity 14
IN STOCKRS-D081018Deucravacitinib Impurity 18-d3 (BMT-153261)
BACK ORDERRS-D081001Deucravacitinib Impurity 19-d3
IN STOCKRS-D081014Deucravacitinib Impurity 29
BACK ORDERRS-D081029Deucravacitinib Impurity 45
CUSTOM SYNTHESISRS-D081034Deucravacitinib Impurity 49-d3
BACK ORDERRS-D081020Deucravacitinib Impurity 61
BACK ORDERRS-D081004Deucravacitinib Impurity 62
IN STOCKRS-D081007Deucravacitinib Impurity 63
CUSTOM SYNTHESISRS-D081009Deucravacitinib Impurity 64
BACK ORDERRS-D081011Deucravacitinib Impurity 65
BACK ORDERRS-D081016Deucravacitinib Impurity 66
IN STOCKRS-D081017Deucravacitinib Impurity 67
IN STOCKRS-D081021Deucravacitinib Impurity 68
IN STOCKRS-D081022Deucravacitinib Impurity 70
CUSTOM SYNTHESISRS-D081026Deucravacitinib Impurity 71
IN STOCKRS-D081027Deucravacitinib Impurity 76
IN STOCKRS-D081040Deucravacitinib Impurity 80
IN STOCKRS-D081044Deucravacitinib Impurity 81
IN STOCKRS-D081045Deucravacitinib Impurity 94
IN STOCKRS-D081002Deucravacitinib Impurity 95
CUSTOM SYNTHESISRS-D081006Deucravacitinib Impurity 96
CUSTOM SYNTHESISRS-D081010Deucravacitinib Impurity 97
IN STOCKRS-D081012Deucravacitinib Impurity 98
CUSTOM SYNTHESISRS-D081013Deucravacitinib Impurity 99
BACK ORDERRS-D081019Deucravacitinib Impurity 101
BACK ORDERRS-D081028Deucravacitinib Impurity 102
BACK ORDERRS-D081031Deucravacitinib Impurity 104
BACK ORDERRS-D081039Deucravacitinib Impurity 124
CUSTOM SYNTHESISRS-U006204
Pharmacopoeial names (EP, USP, BP, JP) are used for identification purposes only and do not imply endorsement by those bodies. This product is supplied for laboratory and research use only — not for human or veterinary use.
















































